Milton, United States
Kalion, Inc. is a US-based startup founded in 2011 with a focus on commercializing new molecules derived in a greener manner. Led by Prof. Kristala Prather from MIT, the company's primary focus is on glucaric acid, identified as a significant challenge with the potential to offer a new platform chemical that could revolutionize various industries. Their success in developing high-purity glucaric acid has paved the way for companies and researchers to leverage its unique properties.
Kalion operates within the biotechnology, industrial, and manufacturing sectors, aiming to bring about substantial advancements in these fields through sustainable and innovative solutions. The company received a notable $946.16K grant investment on 18 June 2020 from the National Science Foundation, showcasing confidence and support from reputable institutions.
The company's commitment to sustainability and the exploration of alternative chemical pathways positions it as an attractive investment opportunity, aligning with the growing demand for eco-friendly and efficient solutions in the market. Kalion's pioneering approach and solid backing make it a compelling prospect for potential venture capital investors looking to support impactful and forward-thinking ventures.
